Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-10-18 4:04 pm Unchanged | 2023-05-01 | 13D | Kala Pharmaceuticals, Inc. KALA | Longitude Capital Partners II LLC | 108,239 4.300% | 0 (Unchanged) | Filing History |
| 2023-08-18 4:18 pm Sale | 2023-08-09 | 13D | RxSight, Inc. RXST | Longitude Capital Partners II LLC | 1,774,559 5.000% | -764,478 (-30.11%) | Filing History |
| 2023-06-05 4:52 pm Purchase | 2023-05-26 | 13D | RxSight, Inc. RXST | Longitude Capital Partners II LLC | 2,539,037 7.500% | 32,065 (+1.28%) | Filing History |
| 2023-03-16 4:19 pm Sale | 2023-03-06 | 13D | Aptinyx Inc. APTX | Longitude Capital Partners II LLC | 192,805 0.300% | -3,451,746 (-94.71%) | Filing History |
| 2023-02-14 4:31 pm Purchase | 2022-12-31 | 13D | Aptinyx Inc. APTX | Longitude Capital Partners II LLC | 3,644,551 5.400% | 137,807 (+3.93%) | Filing History |
| 2023-02-14 4:17 pm Sale | 2022-12-31 | 13G | Rapid Micro Biosystems, Inc. RPID | Longitude Capital Partners II LLC | 4,189,845 11.300% | -2,702 (-0.06%) | Filing History |
| 2023-02-14 4:15 pm Sale | 2022-12-31 | 13D | Kala Pharmaceuticals, Inc. KALA | Longitude Capital Partners II LLC | 108,239 6.300% | -110,042 (-50.41%) | Filing History |
| 2023-01-03 5:04 pm Sale | 2022-12-21 | 13D | Venus Concept Inc. VERO | Longitude Capital Partners II LLC | 231,075 5.000% | -15,015 (-6.10%) | Filing History |
| 2022-02-14 6:38 pm Purchase | 2021-12-31 | 13G | Rapid Micro Biosystems, Inc. RPID | Longitude Capital Partners II LLC | 4,192,547 12.200% | 4,192,547 (New Position) | Filing History |
| 2021-08-13 5:15 pm Purchase | 2021-08-03 | 13D | RxSight, Inc. RXST | Longitude Capital Partners II LLC | 2,506,972 9.100% | 2,506,972 (New Position) | Filing History |
| 2021-02-12 5:12 pm Purchase | 2020-12-31 | 13G | Vaxcyte, Inc. PCVX | Longitude Capital Partners II LLC | 3,108,780 6.100% | 3,108,780 (New Position) | Filing History |
| 2020-03-23 5:00 pm Purchase | 2020-03-13 | 13D | Kala Pharmaceuticals, Inc. KALA | Longitude Capital Partners II LLC | 218,281 10.000% | 102,467 (+88.47%) | Filing History |
| 2020-02-12 4:34 pm Purchase | 2020-01-10 | 13D | Aptinyx Inc. APTX | Longitude Capital Partners II LLC | 3,506,744 8.000% | 316,665 (+9.93%) | Filing History |
| 2020-02-12 4:32 pm Purchase | 2019-12-31 | 13G | Nabriva Therapeutics plc NBRVF | Longitude Capital Partners II LLC | 17,026 4.500% | 977 (+6.08%) | Filing History |
| 2020-02-12 4:24 pm Purchase | 2019-12-31 | 13G | AIMMUNE THERAPEUTICS INC AIMT | Longitude Capital Partners II LLC | 6,215,278 9.800% | 23,750 (+0.38%) | Filing History |